Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2013 · 10-Q
Revenue$75.03M$75.03M−3.3% vs Q1 2012 Net Income$25.67M$25.67M−6.7% vs Q1 2012 EPS Diluted$0.70$0.70−5.4% vs Q1 2012 Gross Profit$55,583,000−4.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$29,263,000−15.0% Free Cash Flowderived$26,748,000−19.8% Margins · derivedGross margin74.1%−1.2 pt vs Q1 2012
Operating margin50.4%−2.4 pt vs Q1 2012
Net margin34.2%−1.3 pt vs Q1 2012
ended Sep 30, 2012 · filed Nov 9, 2012 · 40 d after period end